Health Professionals
Patients & Families
Careers 
OUR TECHNOLOGY • IMMUNOTHERAPY
Guiding the immune system to recognize and fight disease
The immune system is one of the body’s most sophisticated defense systems. It continuously identifies and responds to threats such as infections and abnormal cells, while protecting healthy tissues.
Immunotherapy is an innovative approach that harnesses and guides the natural abilities of the immune system to help fight disease. By understanding how immune cells recognize and respond to abnormal cells, researchers are exploring new ways to develop therapies that work with the body’s own biology.
This approach is opening new possibilities for the development of therapies that use the immune system as an active part of treatment.
What is immunotherapy?
Harnessing the body’s own defense system
Immunotherapy refers to treatments that use or influence the immune system to help prevent, control, or treat disease. Unlike conventional medicines that mainly act on a specific biological target, some immunotherapies work by activating, redirecting, or engineering immune cells so they can recognize and respond to disease more effectively.
The central focus of modern immunotherapy is the use of T cells, a type of immune cell that plays an important role in recognizing and responding to abnormal or infected cells. Researchers are exploring how these cells can be activated, redirected, or genetically modified to support new therapeutic approaches.
This has opened the door to increasingly advanced forms of cell-based and gene-modified therapies, in which living cells themselves can become active therapeutic agents. The idea is both powerful and deeply biological: rather than relying only on medicines designed outside the body, researchers can explore how the body’s own cells might be guided to perform specific therapeutic functions.
How does immunotherapy work?
Guiding immune cells toward a therapeutic purpose. The immune system relies on complex interactions between cells and molecular signals to distinguish healthy tissue from cells that may represent a threat.
01. Stimulate Immunity
Stimulate the immune system to strengthen an existing immune response against abnormal cells.
02. Recognize Targets
Help immune cells better recognize abnormal cells and distinguish them from healthy tissue.
03. Remove Barriers
Remove biological barriers and immunosuppressive signals that prevent effective immune responses.
04. Engineered Cells
Modify immune cells outside the body to introduce new, targeted capabilities before administration.
Why does immunotherapy matter?
Many diseases remain difficult to treat because of their biological complexity. A therapy that can identify or respond to specific characteristics of a disease may offer new ways to address these challenges.
Its potential lies not only in using the immune system as a natural defense mechanism, but also in understanding and engineering immune cells to perform specific therapeutic functions. As scientific understanding continues to advance, immunotherapy may contribute to treatments that are increasingly targeted, personalized, and biologically precise.
For patients, this progress represents the possibility of expanding treatment options and addressing diseases that remain challenging to treat.
Therapeutic potential of immunotherapy
Turning living cells into therapeutic tools. Advances in cell biology, immunology, and genetic engineering enable researchers to explore how living cells can be developed as sophisticated therapeutic tools.
Biological Specificity
Cells are engineered to recognize specific biological signals, respond to disease-associated targets, or perform defined therapeutic functions within the body.
Personalized Medicine
Tailoring treatment strategies to the unique biological characteristics of an individual patient or their disease profile.
Targeted Development
Integrating data about the patient, disease mechanism, and therapeutic cells to guide every step of treatment development.
Immunotherapy and advanced therapies (ATMP)
Some advanced immunotherapies are classified as Advanced Therapy Medicinal Products (ATMPs), a regulatory category that includes certain cell therapies, gene therapies, and tissue-engineered products. These therapies can involve highly specialized processes, from cell collection and genetic modification to manufacturing, quality control, and clinical development.
Because the therapeutic agent may consist of living or genetically modified cells, development requires careful evaluation of factors such as identity, potency, consistency, quality, and safety. These requirements are an important part of translating promising scientific concepts into therapies that can ultimately be evaluated for patients.
Advancing the future of medicine
Immunotherapy is helping redefine how we approach the treatment of disease: not simply by designing medicines that act on the body, but by harnessing and engineering the body’s own biological capabilities.
Our vision is to help translate advances in immunology and cellular engineering into innovative therapeutic approaches that address significant unmet medical needs.